Understanding and Applying New Advances in Basal Insulin Therapy: Comparative Pharmacokinetic, Efficacy, Side Effects (Hypoglycemia), and Safety Profiles for Established and New Longer-Acting Insulin Analogues—Implications for Patient and Insulin Selection Pablo F. Mora, MD, MSc, FAC, CDE

Understanding and Applying New Advances in Basal Insulin Therapy: Comparative Pharmacokinetic, Efficacy, Side Effects (Hypoglycemia), and Safety Profiles for Established and New Longer-Acting Insulin Analogues—Implications for Patient and Insulin Selection Pablo F. Mora, MD, MSc, FAC, CDE


Published

June 25, 2015

Created by

CMEducation Resources symposium